Monday, October 26, 2026 · Daily editionET --:--:--

Under way, not recruiting

Optimization and Standardization of Single-Port Robotic Transanal Minimally Invasive Surgery for Rectal Tumor Excision

NCT07522294 · Jeng-Fu You · Updated 17 April 2026

What is being tested
da Vinci SP Surgical System
For
Rectal Neoplasms; Rectal Cancer Patients; Rectal Benign Lesions
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 20 years to 80 years. About 20 people. The full rules are on the registry page.
Where
Taiwan
When
Starts or started 1 Jan 2026, ends 31 Dec 2029. Registered 13 April 2026.
Results
None posted yet.

In the researchers' words

Title Case Summary: "This study evaluates the safety, feasibility, and short-term clinical outcomes of a new surgical approach called Single-Port (SP) Robotic Transanal Minimally Invasive Surgery (SPR TAMIS) for treating rectal tumors." Content: Transanal Minimally Invasive Surgery (TAMIS) is a standard technique for treating early-stage rectal tumors. However, traditional TAMIS often faces challenges such as restricted vision and instrument crowding in the narrow rectum. The purpose of this study is to establish a standardized surgical procedure using a single-port robotic platform, which provides better flexibility and visualization. The investigators will analyze real-world clinical cases and surgical videos to assess key outcomes, including the success of tumor resection (R0 resection rate), operative safety, and patient recovery parameters. The study aims to provide clinical evidence for this robotic technique and facilitate its standardized implementation in surgical practice.
ClinicalTrials.gov, NCT07522294

Sites

  • Chang Gung Memorial Hospital, LinkouTaoyuan, Taiwan